Literature DB >> 2663526

Sarafotoxin S6b displaces specifically bound 125I-endothelin.

X H Gu1, D J Casley, W G Nayler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2663526     DOI： 10.1016/0014-2999(89)90342-7

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  5 in total

1.  Nifedipine and experimental cardioprotection.

Authors:  W G Nayler; J J Liu; S Panagiotopoulos
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Endothelin: a review of its effects and possible mechanisms of action.

Authors:  W Lovenberg; R C Miller
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

3.  Binding of [125I]-endothelin-1 to rat cerebellar homogenates and its interactions with some analogues.

Authors:  C R Hiley; C R Jones; J T Pelton; R C Miller
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

4.  Structure-activity studies on endothelin (16-21), the C-terminal hexapeptide of the endothelins, in the guinea-pig bronchus.

Authors:  P Rovero; R Patacchini; C A Maggi
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

5.  Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments.

Authors:  J J Maguire; R E Kuc; B A Rous; A P Davenport
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.